Literature DB >> 12270656

Evaluation of PCR-based methods for the quantitation of integrated HIV-1 DNA.

Raman Kumar1, Nick Vandegraaff, Linda Mundy, Christopher J Burrell, Peng Li.   

Abstract

Integration of HIV-1 DNA is essential both for productive viral replication and for viral persistence in patients. Methods to measure specifically proviral HIV DNA are required for investigating the mechanisms of HIV integration, for screening novel integrase inhibitors in cell culture and for monitoring levels of persistent integrated viral DNA in patients. In this report, the linker primer polymerase chain reaction (LP-PCR) and Alu-PCR methods for the quantitation of integrated HIV-1 DNA have been modified and evaluated. Each of the two modified assays allowed the quantitative detection of 4 copies of integrated HIV DNA in presence of 2 x 10(5) cell-equivalents of human chromosomal DNA. The results show that proper DNA isolation procedures and the inclusion of appropriate controls in these assays are important for the accurate quantitation of integrated HIV DNA. With further improvements, it should be possible to use these methods as diagnostic tools to monitor closely the efficacy of antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270656     DOI: 10.1016/s0166-0934(02)00105-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  21 in total

1.  HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.

Authors:  Luis M Agosto; Jianqing J Yu; Jihong Dai; Rachel Kaletsky; Daphne Monie; Una O'Doherty
Journal:  Virology       Date:  2007-07-13       Impact factor: 3.616

2.  The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy.

Authors:  Gang Zhang; Dongwei Guo; Prasanta K Dash; Mariluz Araínga; Jayme L Wiederin; Nicole A Haverland; Jaclyn Knibbe-Hollinger; Andrea Martinez-Skinner; Pawel Ciborowski; Val S Goodfellow; Tadeusz A Wysocki; Beata J Wysocki; Larisa Y Poluektova; Xin-Ming Liu; JoEllyn M McMillan; Santhi Gorantla; Harris A Gelbard; Howard E Gendelman
Journal:  Nanomedicine       Date:  2015-10-22       Impact factor: 5.307

3.  Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.

Authors:  Dongwei Guo; Gang Zhang; Tadeusz A Wysocki; Beata J Wysocki; Harris A Gelbard; Xin-Ming Liu; JoEllyn M McMillan; Howard E Gendelman
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

4.  Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus.

Authors:  Melinda A Brindley; Wendy Maury
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.

Authors:  Tong-Cui Ma; Run-Hong Zhou; Xu Wang; Jin-Biao Liu; Jie-Liang Li; Yu Zhou; Wei Hou; Wen-Zhe Ho
Journal:  Virology       Date:  2017-10-16       Impact factor: 3.616

6.  Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients.

Authors:  F Watzinger; M Suda; S Preuner; R Baumgartinger; K Ebner; L Baskova; H G M Niesters; A Lawitschka; T Lion
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

7.  Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.

Authors:  J M Carr; K M Cheney; C Coolen; A Davis; D Shaw; W Ferguson; G Chang; G Higgins; C Burrell; P Li
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

8.  Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus.

Authors:  Audrey Brussel; Pierre Sonigo
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction.

Authors:  Norio Yamamoto; Chika Tanaka; YuFeng Wu; Myint Oo Chang; Yoshio Inagaki; Yasunori Saito; Toshio Naito; Hitoshi Ogasawara; Iwao Sekigawa; Yasuo Hayashida
Journal:  Virus Genes       Date:  2006-02       Impact factor: 2.332

10.  Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages.

Authors:  Richard Lu; Noriko Nakajima; Wolfgang Hofmann; Monsef Benkirane; Kuan-Teh Jeang; Joseph Sodroski; Alan Engelman; Kuan Teh-Jeang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.